New antiviral therapies cure most patients with hepatitis C and prevent the development of cirrhosis and hepatocellular carcinoma. The major challenges for global hepatitis C virus eradication are the identification of patients with chronic hepatitis C, referrals to treatment, and elevated drug prices. See also pages 000-000.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2EWwnNj
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου